Navigation Links
Endo Pharmaceuticals Completes Acquisition of Indevus Pharmaceuticals
Date:3/23/2009

CHADDS FORD, Pa., March 23 /PRNewswire-FirstCall/ -- Endo Pharmaceuticals (Nasdaq: ENDP) today announced the successful completion of its acquisition of Indevus Pharmaceuticals, Inc. Endo acquired Indevus through a tender offer and subsequent merger upon which Indevus became a wholly owned subsidiary of Endo. The common stock of Indevus ceased trading at market close on March 23, 2009 and has been converted into the right to receive $4.50 per Indevus share in cash and up to an additional $3.00 per share in cash upon achievement of certain regulatory and sales milestones.

About Endo

Endo Pharmaceuticals is a specialty pharmaceutical company engaged in the research, development, sale and marketing of branded and generic prescription pharmaceuticals used primarily to treat and manage pain. Its products include LIDODERM(R), a topical patch to relieve the pain of postherpetic neuralgia; PERCOCET(R) and PERCODAN(R) tablets for the relief of moderate-to-moderately severe pain; FROVA(R) tablets for the acute treatment of migraine attacks with or without aura in adults; OPANA(R) tablets for the relief of moderate-to-severe acute pain where the use of an opioid is appropriate; OPANA(R) ER tablets for the relief of moderate-to-severe pain in patients requiring continuous, around-the-clock opioid treatment for an extended period of time; and VOLTAREN(R) gel, a nonsteroidal anti-inflammatory drug indicated for the relief of the pain of osteoarthritis of joints amenable to topical treatment; Sanctura(R) and its XR version for treatment of overactive bladder, Vantas(R) for the palliative treatment of advanced prostate cancer, and Supprelin(R) for the treatment of early onset puberty in children. The company markets its branded pharmaceutical products to physicians in pain management, neurology, surgery, oncology, and primary care. More information, including this and past press releases of Endo Pharmaceuticals, is available at www.endo.com.


'/>"/>
SOURCE Endo Pharmaceuticals
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. NovaBay Pharmaceuticals Scientific Advisor Receives American Chemical Societys Highest Award
2. Poniard Pharmaceuticals to Focus Company Resources on Late-Stage Oncology Candidate Picoplatin Through Realignment of Research Organization
3. Triax Pharmaceuticals, Providers of the No. 1 Prescribed Mid-Potency Corticosteroid Brand, Introduce a New Size of Locoid Lotion 0.1%
4. Triax Pharmaceuticals, Providers of the No. 1 Prescribed Mid-Potentcy Corticosteroid Brand, Introduce a New Size of Locoid Lotion 0.1%
5. Endo Pharmaceuticals Announces Successful Completion of Tender Offer for Indevus Pharmaceuticals
6. Valeant Pharmaceuticals Appoints President of Valeant Pharmaceuticals International
7. Poniard Pharmaceuticals to Present at Needham & Companys Cancer Therapeutics: Today & Tomorrow Conference
8. Statement by Teva Pharmaceuticals on Eshoo-Barton Bill
9. Poniard Pharmaceuticals Receives Going Concern Qualification
10. China Yongxin Pharmaceuticals Inc. Launches Electronic Diagnosis System in its Changchun Drugstores
11. Transcept Pharmaceuticals to Report Fourth Quarter 2008 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2016)... ... 24, 2016 , ... American Gene Technologies International, Inc ... its board of directors. Otterstatter is co-founder, president and CEO of Preventice, ... that lead to broad-based healthcare solutions. , “Jon knows how to create disruptive ...
(Date:5/24/2016)... ... 24, 2016 , ... Tuesday, May 24, Women's Excellence in Wellness, powered by ... Living Essential Oils, taught by Patti Dolan, RYT, a Young Living Gold Member. ... is 6:30pm - 7:15pm followed by a small intro to the Oils that can ...
(Date:5/24/2016)... Los Angeles, CA (PRWEB) , ... May 24, 2016 , ... ... Hospital successfully performed the first penis transplant in the United States . The ... being diagnosed with penile cancer. The transplant could restore not only a natural appearance, ...
(Date:5/24/2016)... , ... May 24, 2016 , ... Controlling and maintaining ... with the launch of the Aquanta Water Heater Controller , a first-of-its-kind system ... or web-enabled device. As the Nest thermostat does for HVAC systems, Aquanta gives ...
(Date:5/24/2016)... ... May 24, 2016 , ... Local chiropractor Dr. Jason ... 21, 2016. Dr. Gerard, who holds a Doctorate of Chiropractic and Bachelors of ... health and wellness in Third World countries where resources are limited. , ChiroMission ...
Breaking Medicine News(10 mins):
(Date:5/24/2016)... 24, 2016 The innovator ... , s first dual therapy stent, introduces ... OrbusNeich, a global company specializing in the ... to include products to treat peripheral artery disease. The ... entry devices for lower limb and arteriovenous (AV) fistula ...
(Date:5/24/2016)... , May 24, 2016 ... ™ , la première endoprothèse ... cathéters destinés à l,intervention portant sur les ...   OrbusNeich, entreprise mondiale spécialisée ... de changer la vie, a élargi son ...
(Date:5/24/2016)... , May 24, 2016 Dutch surgeons ... best practices around the world and treat patients on a global ... Africa , Asia and the US ... with instant messaging and networking in a totally secure environment. ... in a war zone working together with a surgeon at Harvard ...
Breaking Medicine Technology: